Rubinstein-Taybi because of a novel EP300 mutation with novel clinical findings.

Clin Dysmorphol

aDepartment of Pediatrics bJagiellonian University Medical College, Kraków cDepartment of Medical Genetics, Institute of Mother and Child, Warsaw, Poland dJeroen KJ van Houdt, Center for Human Genetics, University Hospital Gasthuisberg, Catholic University Leuven, Leuven, Belgium.

Published: July 2017

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCD.0000000000000164DOI Listing

Publication Analysis

Top Keywords

rubinstein-taybi novel
4
novel ep300
4
ep300 mutation
4
mutation novel
4
novel clinical
4
clinical findings
4
rubinstein-taybi
1
ep300
1
mutation
1
novel
1

Similar Publications

Rubinstein-Taybi syndrome (RSTS) is a rare autosomal dominant neurodevelopmental disorder linked to haploinsufficiency of CREBBP (RSTS1) and EP300 (RSTS2) genes. Characteristic features often include distinctive facial traits, broad thumbs and toes, short stature, and various degrees of intellectual disability. The clinical presentation of RSTS is notably variable, making it challenging to establish a clear genotype-phenotype correlation, except for specific variants which cause the allelic Menke-Hennekam syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • A 15-day-old male infant with Rubinstein-Taybi Syndrome (RTS) was diagnosed with unilateral congenital glaucoma in his left eye, presenting with corneal enlargement and haze.
  • Imaging showed significant eye abnormalities, including iris atrophy and adhesions related to a cataractous lens.
  • Genetic testing revealed a new harmful variant in the CREBBP gene, and treatment involved a laser procedure to manage intraocular pressure.
View Article and Find Full Text PDF
Article Synopsis
  • Histone deacetylases (HDACs) are crucial for modifying histones, influencing gene expression and chromatin structure, with Class I HDACs being widely expressed and involved in protein complexes.
  • A study identified a novel mutation in the HDAC2 gene in a patient with Rubinstein-Taybi syndrome (RSTS), who initially tested negative for known RSTS mutations, suggesting a connection between this mutation and chromatinopathies.
  • Investigations revealed that the HDAC2 mutation caused improper localization in the nucleus, altered protein levels, and distinct patterns of gene expression, highlighting HDAC2's potential role in chromatin-related disorders.
View Article and Find Full Text PDF

Rubinstein-Taybi syndrome (RSTS) is an extremely rare genetic disorder affecting multi-organ systems. A tendency to form keloid is one of the common dermatologic manifestations. We describe a 23-year-old female presented with extensive keloids which developed spontaneously.

View Article and Find Full Text PDF

Background: Intellectual disability (ID) can be associated with different syndromes such as Rubinstein-Taybi syndrome (RSTS) and can also be related to conditions such as metabolic encephalomyopathic crises, recurrent,with rhabdomyolysis, cardiac arrhythmias and neurodegeneration. Rare congenital RSTS1 (OMIM 180849) is characterized by mental and growth retardation, significant and duplicated distal phalanges of thumbs and halluces, facial dysmorphisms, and an elevated risk of malignancies. Microdeletions and point mutations in the CREB-binding protein (CREBBP) gene, located at 16p13.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!